All-cause mortality benefit with ICD use in STEMI patients treated with primary PCI3' education - Sep. 3, 2019 - Danielle Haanschoten - Zwolle, The Netherlands
This video was recorded at the ESC in Paris, France, on September 3, 2019.
Danielle Haanschoten, MD, Isala Hartcentrum, Zwolle, The Netherlands.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.